Phathom Pharmaceuticals, Inc. PHAT
5.74 USD -0.17 (-2.96%)
At closeNov 3, 2026, 4:06 PM EST
5.74 0.00 0.00%
After hours · Nov 3, 4:06 PM ET
5.50 Day range 6.11
5.02 52-week range 18.31
- YTD
- -65.40%
- 1 year
- -58.19%
Held by funds
73 US ETFs and mutual funds hold PHAT · largest positions
Ownership
Held by insiders 4.58%
Held by institutions 83.10%
Float held by institutions 87.09%
Institutions 230
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 15.69% | 12,466,489 | 146.23M | Dec 30, 2025 |
| Medicxi Ventures Management (Jersey) Ltd | 9.40% | 7,464,572 | 87.56M | Mar 30, 2026 |
| Invesco Ltd. | 4.94% | 3,920,446 | 45.99M | Dec 30, 2025 |
| Blackrock Inc. | 4.48% | 3,555,548 | 41.71M | Dec 30, 2025 |
| Carlyle Group Inc. | 4.40% | 3,496,808 | 41.02M | Dec 30, 2025 |
| Vanguard Group Inc | 4.00% | 3,177,211 | 37.27M | Dec 30, 2025 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| AIM Intl Mutual Fd.s -Invesco Global Fd. | 2.95% | 2,342,451 | 27.48M | Jan 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.29% | 1,821,569 | 21.37M | Dec 30, 2025 |
| iShares Trust-iShares Russell 2000 ETF | 1.24% | 982,131 | 11.52M | Feb 27, 2026 |
| Fidelity Rutland Square TRT II-Strategic Advisers U.S. Total Stock Fd. | 1.22% | 968,545 | 11.36M | Feb 27, 2026 |
| WASATCH FUNDS TRUST-Wasatch Micro Cap Fund | 0.94% | 749,134 | 8.79M | Dec 30, 2025 |
| WASATCH FUNDS TRUST-Wasatch Ultra Growth Fund | 0.71% | 563,443 | 6.61M | Dec 30, 2025 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BASTA STEVEN L | Chief Executive Officer | Stock Award(Grant) | Feb 9, 2026 | 373,315 |
| BREEDLOVE ROBERT CHARLES | Officer | Stock Award(Grant) | Feb 26, 2026 | 68,425 |
| COOK ANNE MARIE | Officer | Stock Award(Grant) | Feb 9, 2026 | 88,660 |
| CURRAN TERRIE | President | Sale | Jan 20, 2025 | 364,305 |
| HENDERSON MOLLY | Chairman of the Board | Sale | Apr 6, 2025 | 91,779 |
| NABULSI AZMI M.D. | Chief Operating Officer | Stock Award(Grant) | Feb 26, 2025 | 1,101,870 |
